We are open with limited hours and staff.
Price range: $194.00 through $817.00
is a historical prescription combination containing 7.5mg of hydrocodone bitartrate and 750mg of acetaminophen per tablet. Hydrocodone belongs to the opioid analgesic class, while acetaminophen provides additional pain-relieving and fever-reducing effects. Historical DailyMed labeling documents this strength as an oral tablet formulation.
Because this formulation contains a substantial amount of acetaminophen, its safety profile deserves careful consideration. At the same time, hydrocodone carries important opioid-related risks, including sedation, respiratory depression, misuse, dependence, and overdose.
This medication combines two active ingredients that work through different mechanisms. Hydrocodone acts on opioid receptors within the central nervous system and changes how the body perceives pain. Acetaminophen provides additional analgesic effects through a separate mechanism.
Therefore, treatment requires consideration of both components. A qualified healthcare professional should review a patient’s medical history, other medicines, previous opioid exposure, and individual risk factors before determining whether an opioid-acetaminophen combination is appropriate.
Historical hydrocodone-acetaminophen labeling describes these tablets for oral administration and pain management. The archived labeling specifically documents the 7.5mg/750mg strength.
However, historical labeling should not be interpreted as confirmation that this exact strength remains approved or commercially available in every jurisdiction. Consequently, patients should verify current product information with an appropriate healthcare professional or regulatory authority.
Hydrocodone can cause significant central nervous system effects. These may include drowsiness, impaired alertness, and respiratory depression. Moreover, opioid medicines carry risks associated with misuse, abuse, addiction, overdose, and potentially fatal breathing problems.
Acetaminophen creates an additional concern. Excessive exposure can result in serious liver injury, especially when a person combines multiple acetaminophen-containing medicines. Historical labeling warns that acetaminophen-related liver injury has been associated with excessive daily exposure.
For this reason, patients should tell their healthcare professional about all prescription medicines, over-the-counter products, supplements, and alcohol use.
Potential effects associated with hydrocodone-acetaminophen may include:
Additionally, excessive acetaminophen exposure may cause serious liver injury. Symptoms of severe toxicity require prompt medical evaluation.
Emergency medical assistance should be sought for severe breathing difficulty, extreme sedation, loss of consciousness, or suspected opioid overdose.
Hydrocodone-containing medication should only be used under appropriate medical supervision. Patients should follow the instructions provided for their specific prescription and should never share an opioid medicine with another person.
Likewise, additional acetaminophen-containing products should not be combined with this type of medication without professional guidance. This precaution matters particularly with the historical 750mg acetaminophen formulation.
Alcohol, sedatives, benzodiazepines, and other central nervous system depressants can further increase sedation and respiratory risks. Therefore, patients should discuss these substances with their healthcare provider.
The 7.5mg/750mg strength is documented in archived DailyMed labeling, which identifies each tablet as containing 7.5mg hydrocodone bitartrate and 750mg acetaminophen. Historical labeling also identifies a five-tablet maximum in its dosage information for that formulation.
Importantly, historical dosage information should not be used as personal dosing instructions. Current prescribing information may differ, and individual treatment depends on the specific product and patient.
The 7.5mg/750mg strength should also be distinguished from formulations containing lower amounts of acetaminophen, such as 7.5mg/325mg products.
Acetaminophen appears in many prescription and nonprescription medicines. As a result, taking several products that contain the ingredient can unintentionally increase total exposure.
People with liver disease, significant alcohol use, or other relevant risk factors should discuss acetaminophen use with a healthcare professional. Furthermore, patients should check medication labels carefully before adding another pain reliever.
Hydrocodone 7.5mg/750mg combines an opioid analgesic with acetaminophen, so both opioid-related and liver-related safety considerations are important. The 7.5mg/750mg formulation is documented in historical DailyMed records, but current availability and regulatory status should be verified for the applicable jurisdiction.
